Asset
SOMATROGON
Revenue
No revenue reported in loaded filings.
Clinical trials (9)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03810664 | phase1 | completed | 2019-01-18 | 2019-04-19 | OPKO Health, Inc. | A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations |
| NCT01909479 | phase3 | terminated | 2013-06-01 | 2016-08-01 | OPKO Health, Inc. | A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency |
| NCT02500316 | phase2 | completed | 2014-02-01 | 2023-11-01 | OPKO Health, Inc. | Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children |
| NCT01225666 | phase2 | completed | 2010-08-01 | 2011-07-01 | OPKO Health, Inc. | MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA) |
| NCT01060722 | phase1 | completed | 2009-10-01 | 2010-01-01 | OPKO Health, Inc. | MOD-4023 Study in Healthy Male Volunteers |
FDA applications (0)
This company has no applications containing this asset.